| Breakdown | TTM | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 132.81B | 140.62B | 126.95B | 114.85B | 91.33B | 84.78B |
| Gross Profit | 56.07B | 58.34B | 51.41B | 41.20B | 33.09B | 30.52B |
| EBITDA | 18.98B | 20.39B | 16.92B | 10.06B | 4.70B | 5.82B |
| Net Income | 16.58B | 16.74B | 11.46B | 6.24B | 1.35B | 2.81B |
Balance Sheet | ||||||
| Total Assets | 127.32B | 141.36B | 123.52B | 114.41B | 106.40B | 85.97B |
| Cash, Cash Equivalents and Short-Term Investments | 17.34B | 24.28B | 16.11B | 11.79B | 15.38B | 14.35B |
| Total Debt | 16.16B | 14.23B | 20.45B | 18.45B | 20.58B | 10.37B |
| Total Liabilities | 46.99B | 51.59B | 50.90B | 52.97B | 53.89B | 38.09B |
| Stockholders Equity | 79.86B | 89.35B | 72.19B | 61.04B | 52.11B | 47.88B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 19.00B | 8.30B | 1.03B | -8.11B | 3.06B |
| Operating Cash Flow | 0.00 | 21.37B | 10.82B | 2.71B | -6.49B | 6.19B |
| Investing Cash Flow | 0.00 | -3.28B | -4.59B | -3.59B | -3.03B | -4.39B |
| Financing Cash Flow | 0.00 | -11.44B | -2.70B | -3.56B | 8.26B | -3.52B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥67.39B | 10.81 | ― | 1.12% | 18.83% | 55.54% | |
78 Outperform | ¥46.54B | 9.33 | ― | 3.21% | 8.90% | 35.83% | |
75 Outperform | ¥54.81B | 9.50 | ― | 1.94% | -2.66% | -9.83% | |
71 Outperform | ¥122.15B | 17.71 | ― | 2.20% | 8.69% | 74.50% | |
68 Neutral | ¥193.67B | 18.29 | ― | 1.88% | 10.76% | 46.03% | |
67 Neutral | ¥33.24B | 6.33 | ― | 2.29% | 12.40% | 7.55% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |